Pacira Pharmaceuticals CEO David Stack's 2019 pay slips 1% to $5.8M
Pacira Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Pacira Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Pacira Pharmaceuticals received on average a compensation package of $3M, a 8% increase compared to previous year.
Average pay of disclosed executives at Pacira Pharmaceuticals
David Stack, Chief Executive Officer, received $5.8M in total, which decreased by 1% compared to 2018. 56% of Stack's compensation, or $3.2M, was in option awards. Stack also received $625K in bonus, $832K in salary, $1.1M in stock awards, as well as $17K in other compensation.
For fiscal year 2019, the median employee pay was $155,462 at Pacira Pharmaceuticals. Therefore, the ratio of David Stack's pay to the median employee pay was 37 to one.
Max Reinhardt, President, received a compensation package of $4.6M. 91% of the compensation package, or $4.1M, was in option awards.
Kristen Williams, Chief Administrative Officer, earned $1.7M in 2019, a 13% decrease compared to previous year.
Roy Winston, Chief Clinical Officer, received $1.6M in 2019.
Charles A. Reinhart, III, Chief Financial Officer, earned $1.4M in 2019, a 1% decrease compared to previous year.
Related executives
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
Charles Reinhart
Pacira Pharmaceuticals
Chief Financial Officer
Max Reinhardt
Pacira Pharmaceuticals
President, Rest of World
Kristen Williams
Pacira Pharmaceuticals
Chief Administrative Officer
Roy Winston
Pacira Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 24, 2020.